PRISM is seeking academic support to establish a pilot study of MDMA-Assisted Manualised Psychotherapy in Australian war veterans with chronic, treatment-resistant Posttraumatic Stress Disorder (PTSD), in collaboration with the US based Multidisciplinary Association for Psychedelic Studies (MAPS). For more information please contact us.
MAPS coordinated MDMA-PTSD studies are currently underway in the USA, Canada and Israel. For information on MAPS studies please visit http://www.maps.org/research/mdma
Strauss, N., Bright, S. J., & Williams, M. L. (2016). Australia should be initiating a psychedelic research program: What are the barriers? Australian and New Zealand Journal of Psychiatry, 50(11), 1036-1037. http://journals.sagepub.com/doi/full/10.1177/0004867416670520
Response (not a PRISM publication): Puspanathan, P. (2017). Psychedelic research in Australia: Breaking through the stigma.
Australian and New Zealand Journal of Psychiatry. http://journals.sagepub.com/doi/pdf/10.1177/0004867417701580
We are not currently hiring. Please subscribe to our mailing list for updates on future opportunities.
For students, we’re sorry to advise that Australia is lagging far beyond other countries in terms of psychedelic research. All PhDs so far have been confined to survey based research or people have travelled overseas. The best advice we can give is to complete your honours in a related field (eg psychology, brain-imaging, neuroscience, anthropology etc) and then seek support to do a PhD.